Is ANNX Worth Buying in 2026?

Annexon, Inc. Common Stock

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-08-16

Here’s whether Annexon, Inc. Common Stock (ANNX) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Neutral.

🔵
Neutral

Positives: trading above the 200-day MA (long-term uptrend intact); RSI 55 — healthy momentum range; strong 1-year return of +122.3%. Concerns: below the 50-day MA (medium-term momentum negative); declining volume on rally — weak conviction (0.71x 30d avg). Currently 26.3% off its 52-week high. Score: +2/7.

Ready to act on this? 📈 Trade on Webull

ANNX is holding above its long-term 200-day MA ($5.24) but has slipped below the 50-day MA ($5.36), pointing to short-term weakness in an otherwise intact trend. An RSI of 54.6 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +122.3% compares to +20.4% for SPY (beat the market by 101.9%). The current 26.3% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $22,227 today
vs. S&P 500 (SPY) — same period beat market by 101.9%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($5.24)
Above 50-day MA ($5.36)
RSI(14) neutral zone (30–70) — currently 54.6
Positive return (+122.3%)
!Within 10% of period high (−26.3%)
Period Range $5.29
$2.03 $7.18
RSI (14) 54.6
0 · OversoldOverbought · 100

Key Metrics

Price$5.29
Period Return+122.3%
Period High$7.18
Period Low$2.03
Drawdown−26.3%
MA-50$5.36
MA-200$5.24
RSI (14)54.6
Avg Volume (30d)3.5M
vs. SPYbeat by 101.9%
Return Rank#126 of 1252

Trade ANNX

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers